Douglas Hay
General Counsel bij TENAX THERAPEUTICS, INC.
Profiel
Douglas Hay was the founder of Phyxius Pharma, Inc. (founded in 2010) where he held the title of Vice President-Regulatory Affairs from 2010 to 2013.
He is currently working at Tenax Therapeutics, Inc. as Senior Vice President-Regulatory Affairs since 2013.
Previously, he worked at Bristol Myers Squibb Co. from 1999 to 2005 as Vice President-Global Regulatory Sciences.
Dr. Hay completed his graduate degree from The California State University in 1978, his doctorate degree from Northern Arizona University in 1983, and his undergraduate degree from the University of California, Riverside in 1975.
Actieve functies van Douglas Hay
| Bedrijven | Functie | Begin |
|---|---|---|
| TENAX THERAPEUTICS, INC. | General Counsel | 14-11-2013 |
Eerdere bekende functies van Douglas Hay
| Bedrijven | Functie | Einde |
|---|---|---|
Phyxius Pharma, Inc.
 Phyxius Pharma, Inc. Pharmaceuticals: MajorHealth Technology Part of Tenax Therapeutics, Inc., Phyxius Pharma, Inc. provides pharmaceutical products. The private company is based in Chester, NJ. The company was founded by Doug Randall, Douglas Hay, John P. Kelley. Phyxius Pharma was acquired by Life Newco, Inc. on November 13, 2013 for $32.66 million. | Founder | 01-11-2013 |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01-03-2005 |
Opleiding van Douglas Hay
| The California State University | Graduate Degree |
| Northern Arizona University | Doctorate Degree |
| University of California, Riverside | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| TENAX THERAPEUTICS, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Phyxius Pharma, Inc.
Phyxius Pharma, Inc. Pharmaceuticals: MajorHealth Technology Part of Tenax Therapeutics, Inc., Phyxius Pharma, Inc. provides pharmaceutical products. The private company is based in Chester, NJ. The company was founded by Doug Randall, Douglas Hay, John P. Kelley. Phyxius Pharma was acquired by Life Newco, Inc. on November 13, 2013 for $32.66 million. | Health Technology |
